Click a link below to view the mailing archive as if it had been sent to you.
| 2025-05-30 12:15 | | #ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer and more... |
| 2025-05-30 00:15 | | Astellas aspires to strike CLDN18.2 gold again with ADC licensing deal worth up to $1.34B and more... |
| 2025-05-29 12:15 | | Drugmakers, trade groups and others voice concerns with pharma-specific tariffs and more... |
| 2025-05-29 00:15 | | Novartis emerged victorious in multi-month pursuit of Regulus and potential kidney blockbuster, filing shows and more... |
| 2025-05-28 12:15 | | GLP-1 prescriptions for weight loss soar, despite obstacles and more... |
| 2025-05-28 00:15 | | AbbVie's Allergan Aesthetics unit plots 202 layoffs after recent sales slide and more... |
| 2025-05-27 12:15 | | Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics and more... |
| 2025-05-23 12:15 | | Merus hails 'unprecedented' survival on solid tumor bispecific, sparking stock jump and more... |
| 2025-05-23 00:15 | | ASCO: Roche, Jazz's Zepzelca small cell lung cancer win leaves room for improvement and more... |
| 2025-05-22 12:15 | | Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race and more... |
| 2025-05-22 00:15 | | FDA expands warnings of heart risks on COVID shots and more... |
| 2025-05-21 12:15 | | As Eli Lilly outperforms Novo in market, it also replaces its rival in annual IDEA Innovation rankings and more... |
| 2025-05-21 00:15 | | Schrödinger lays off 60 staffers amid ‘uncertain times and challenging economic conditions’ and more... |
| 2025-05-20 12:15 | | FDA outlines stricter Covid vaccine booster approval standards for healthy people and more... |
| 2025-05-20 00:15 | | Prime Medicine CEO exits as biotech shelves sole clinical gene therapy, lays off 25% of staff and more... |
| 2025-05-19 12:15 | | Regeneron wins bid to buy 23andMe out of bankruptcy and more... |
| 2025-05-19 00:15 | | Sarepta Seeks to Strengthen Elevidys’ Case With Data in Older Kids and more... |
| 2025-05-16 12:15 | | Novo CEO to depart as obesity drugmaker’s challenges rise and more... |
| 2025-05-16 00:15 | | After FDA Cuts, Planning for Upcoming ODAC Meeting Has Been ‘Absolute Chaos’ and more... |
| 2025-05-15 12:15 | | FDA approves Amneal's self-administered migraine treatment and more... |
| 2025-05-15 00:15 | | US health chief Kennedy clashes with lawmakers over vaccine comments and more... |
| 2025-05-14 12:15 | | AbbVie pays ADARx $335M cash for next-gen siRNA options and more... |
| 2025-05-13 12:15 | | GSK axes $625M TIGIT drug as midphase data disappoint, promoting partner iTeos to cut costs and more... |
| 2025-05-13 00:15 | | Medicare lays out timeline for third round of drug price negotiations and more... |
| 2025-05-12 12:15 | | Vir’s hepatitis B combo falls short in Phase II trial and more... |
| 2025-05-12 00:15 | | Trump says he will sign order aimed at cutting drug prices to match other countries and more... |
| 2025-05-09 12:15 | | FDA chief Martin Makary sets June deadline for genAI rollout and more... |
| 2025-05-09 00:15 | | In first oncology expert meeting under Makary, FDA spotlights cancer drugs from J&J, Pfizer, Roche and UroGen and more... |
| 2025-05-08 12:15 | | J&J survey finds pace of oncology innovation is overwhelming physicians and more... |
| 2025-05-08 00:15 | | US judge sides with FDA's removal of Lilly's weight loss drug from shortage list and more... |
| 2025-05-07 12:15 | | Novo's Wegovy takes a hit from compounders, but company expects faster second-half growth and more... |
| 2025-05-07 00:15 | | FDA's top inspector abruptly retires and more... |
| 2025-05-06 12:15 | | 'Now is not the time to retreat': BMS CEO blasts Trump admin tariffs, health reforms amid $40B US investment pledge and more... |
| 2025-05-06 00:15 | | Bristol Myers charts 500-plus new layoffs in NJ following expanded cost savings drive and more... |
| 2025-05-05 12:15 | | Novo’s Wegovy inches closer to becoming first FDA-approved GLP-1 weight-loss pill and more... |
| 2025-05-05 00:15 | | Why Eli Lilly, Viking Therapeutics, and Novo Nordisk Stocks All Popped Friday and more... |
| 2025-05-02 12:15 | | Low-price drug nations catching ‘free ride’ on US innovation, report says and more... |
| 2025-05-02 00:15 | | WHO set to back use of weight-loss drugs for adults globally, raises cost issue and more... |
| 2025-05-01 12:15 | | CVS to boost access to Novo Nordisk’s weight loss treatment Wegovy for patients on its drug plans and more... |
| 2025-05-01 00:15 | | Sanofi nets €10B from Opella stake sale, eyes more 'bolt-on' deals and more... |
